v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)
$ in Thousands
Total
Conversion of Warrants
Conversion of Debt
Common Stock
Common Stock
Conversion of Warrants
Common Stock
Conversion of Debt
Additional Paid- in Capital
Additional Paid- in Capital
Conversion of Warrants
Additional Paid- in Capital
Conversion of Debt
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2023       3,041,492              
Beginning balance at Dec. 31, 2023 $ (43,178)     $ 3     $ 176,979     $ (220,049) $ (111)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Shares issued for settlement of debt and warrants (in shares)         14,440 94,130          
Shares issued for settlement of debt and warrants   $ 6 $ 1,412         $ 6 $ 1,412    
Foreign currency translation adjustment 121                   121
Net income (loss) (18,624)                 (18,624)  
Ending balance (in shares) at Sep. 30, 2024       3,150,062              
Ending balance at Sep. 30, 2024 (60,263)     $ 3     178,397     (238,673) 10
Beginning balance (in shares) at Jun. 30, 2024       3,150,062              
Beginning balance at Jun. 30, 2024 (39,606)     $ 3     178,397     (218,016) 10
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income (loss) (20,657)                 (20,657)  
Ending balance (in shares) at Sep. 30, 2024       3,150,062              
Ending balance at Sep. 30, 2024 (60,263)     $ 3     178,397     (238,673) 10
Beginning balance (in shares) at Dec. 31, 2024       8,543,686              
Beginning balance at Dec. 31, 2024 (12,717)     $ 9     238,685     (251,421) 10
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Stock-based compensation (in shares)       4,787              
Stock-based compensation $ 3,630           3,630        
Stock options exercised (in shares) 25,000     25,167              
Stock options exercised $ 375           375        
Shares granted in lieu of board of director fees (in shares)       2,524              
Shares granted in lieu of board of director fees 77           77        
Net income (loss) 5,704                 5,704  
Ending balance (in shares) at Sep. 30, 2025       8,576,164              
Ending balance at Sep. 30, 2025 (2,931)     $ 9     242,767     (245,717) 10
Beginning balance (in shares) at Jun. 30, 2025       8,568,005              
Beginning balance at Jun. 30, 2025 (14,775)     $ 9     241,248     (256,042) 10
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Stock-based compensation 1,397           1,397        
Stock options exercised (in shares)       8,159              
Stock options exercised 122           122        
Net income (loss) 10,325                 10,325  
Ending balance (in shares) at Sep. 30, 2025       8,576,164              
Ending balance at Sep. 30, 2025 $ (2,931)     $ 9     $ 242,767     $ (245,717) $ 10